Xvivo Perfusion AB Statistics

Total Valuation

LON:0RKL has a market cap or net worth of GBP 1.07 billion. The enterprise value is 1.05 billion.

Market Cap	1.07B
Enterprise Value	1.05B

Important Dates

The last earnings date was Monday, January 27, 2025.

Earnings Date	Jan 27, 2025
Ex-Dividend Date	n/a

Share Statistics

Current Share Class	n/a
Shares Outstanding	n/a
Shares Change (YoY)	+5.73%
Shares Change (QoQ)	-0.11%
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	25.00M

Valuation Ratios

The trailing PE ratio is 86.38.

PE Ratio	86.38
Forward PE	n/a
PS Ratio	n/a
PB Ratio	n/a
P/TBV Ratio	10.43
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 94.01, with an EV/FCF ratio of 356.74.

EV / Earnings	84.10
EV / Sales	17.10
EV / EBITDA	94.01
EV / EBIT	159.15
EV / FCF	356.74

Financial Position

The company has a current ratio of 4.58, with a Debt / Equity ratio of 0.02.

Current Ratio	4.58
Quick Ratio	3.30
Debt / Equity	0.02
Debt / EBITDA	0.23
Debt / FCF	0.84
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is 8.40% and return on invested capital (ROIC) is 2.65%.

Return on Equity (ROE)	8.40%
Return on Assets (ROA)	2.40%
Return on Invested Capital (ROIC)	2.65%
Return on Capital Employed (ROCE)	3.97%
Revenue Per Employee	349,157
Profits Per Employee	73,100
Employee Count	170
Asset Turnover	0.36
Inventory Turnover	1.12

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +63.20% in the last 52 weeks. The beta is 2.09, so LON:0RKL's price volatility has been higher than the market average.

Beta (5Y)	2.09
52-Week Price Change	+63.20%
50-Day Moving Average	464.71
200-Day Moving Average	468.92
Relative Strength Index (RSI)	47.65
Average Volume (20 Days)	1,885

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, LON:0RKL had revenue of GBP 59.36 million and earned 12.43 million in profits. Earnings per share was 0.39.

Revenue	59.36M
Gross Profit	44.49M
Operating Income	6.38M
Pretax Income	14.43M
Net Income	12.43M
EBITDA	10.79M
EBIT	6.38M
Earnings Per Share (EPS)	0.39

Full Income Statement

Balance Sheet

The company has 29.99 million in cash and 2.46 million in debt, giving a net cash position of 27.53 million.

Cash & Cash Equivalents	29.99M
Total Debt	2.46M
Net Cash	27.53M
Net Cash Per Share	n/a
Equity (Book Value)	155.66M
Book Value Per Share	4.94
Working Capital	45.87M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 8.03 million and capital expenditures -5.10 million, giving a free cash flow of 2.93 million.

Operating Cash Flow	8.03M
Capital Expenditures	-5.10M
Free Cash Flow	2.93M
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross margin is 74.95%, with operating and profit margins of 10.74% and 20.94%.

Gross Margin	74.95%
Operating Margin	10.74%
Pretax Margin	24.31%
Profit Margin	20.94%
EBITDA Margin	18.19%
EBIT Margin	10.74%
FCF Margin	4.94%

Dividends & Yields

LON:0RKL does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-5.73%
Shareholder Yield	-5.73%
Earnings Yield	1.16%
FCF Yield	0.27%

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

LON:0RKL has an Altman Z-Score of 32.55.

Altman Z-Score	32.55
Piotroski F-Score	n/a